CompletedPhase 4

The XLIMUS-DES in Very Complex Lesions

Italy200 participantsStarted 2014-08

Plain-language summary

Stent delivery failure occurs in 4% of all percutaneous coronary interventions (PCI) and \>90% of these failures are due to vessel tortuosity and/or calcification. The XLIMUS eluting coronary stent (CARDIONOVUM GmbH, Bonn, Germany) is a new type of endovascular prostheses characterised by better mechanical properties than traditional DES. This is a prospective, non-randomized, single-center pilot study, aiming to evaluate the performance of the XLIMUS DES in severely complex coronary lesions in real-world clinical practice.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * chronic total occlusion (CTO) * severe calcification * severe tortuosity Exclusion Criteria: • coronary artery lesions non satisfying the inclusion criteria

What they're measuring

Stent Performance

Timeframe: up to 1 month

Trial details

NCT IDNCT02360020

SponsorClinica Mediterranea

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-12

View on ClinicalTrials.gov More Coronary Atherosclerosis Due to Calcified Coronary Lesion trials